In the realm of immunology, nanomaterials serve as adjuvants, capable of amplifying immune responses by mimicking the size and shapes of pathogens, which facilitates enhanced antibody production, T-cell activation, and comprehensive immune system stimulation. The versatility of nanomaterials enables creation of various nanoparticle platforms, including polymeric nanoparticles, lipid-based carriers, and inorganic nanoparticles have demonstrated efficacy in delivering antigens, adjuvants, and immunomodulatory agents with increased precision and efficiency. By improving antigen uptake and presentation by immune cells, such as dendritic cells, nanomaterials foster superior antigen processing and immune activation. These advancements hold profound implications for the development of next-generation vaccines and therapies for disease prevention in animals. This chapter delves into the mechanisms, applications, and future potential of nanomaterials in veterinary immunology. It explores the design and optimization of nanoparticle systems, addressing the challenges and opportunities they present. By analysing ongoing research and emerging technologies, this chapter provides insights into the revolutionary role of nanomaterials in shaping the future of animal healthcare and disease management.